Aditxt, Inc. Earnings Per Share (Basic)
Aditxt, Inc. (ADTX) reported Earnings Per Share (Basic) of -$790.49 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-05-20
- Aditxt, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$790.49.
- Aditxt, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$548.78.
- Aditxt, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$3.45.
- Aditxt, Inc. earnings per share, basic for the quarter ending 2025-03-31 was -$198072.98.
- Aditxt, Inc. earnings per share, basic for fiscal 2025 was -$1153.83.
- Aditxt, Inc. earnings per share, basic for fiscal 2024 was -$22147415.22.
- Aditxt, Inc. earnings per share, basic for fiscal 2023 was -$27038.26.
- Aditxt, Inc. earnings per share, basic for fiscal 2022 was -$597.12.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$790.49 10-Q · filed 2026-05-20 | |||||||
| 2025-12-31 | -$1153.83 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | -$548.78 10-Q · filed 2025-11-18 | -$1605.17 10-Q · filed 2025-11-18 | ||||||
| 2025-06-30 | -$3.45 10-Q · filed 2025-08-14 | -$9.22 10-Q · filed 2025-08-14 | ||||||
| 2025-03-31 | -$198072.98 10-Q · filed 2026-05-20 | -$8.12 10-Q · filed 2025-05-15 | ||||||
| 2024-12-31 | -$22147415.22 10-K · filed 2026-03-31 | -$3062.51 10-K · filed 2025-03-31 | ||||||
| 2024-09-30 | -$3137695.20 10-Q · filed 2025-11-18 | -$111.07 10-Q · filed 2024-11-18 | -$14770865.91 10-Q · filed 2025-11-18 | -$522.86 10-Q · filed 2024-11-18 | ||||
| 2024-06-30 | -$1047.17 10-Q · filed 2025-08-14 | -$4.19 10-Q · filed 2024-08-19 | -$3262.64 10-Q · filed 2025-08-14 | -$13.05 10-Q · filed 2024-08-19 | ||||
| 2024-03-31 | -$91439.43 10-Q · filed 2025-05-15 | -$9.14 10-Q · filed 2024-05-20 | ||||||
| 2023-12-31 | $1592.34 derived: net income ÷ weighted average shares · filed 2025-03-31 | $22106.13 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$525.41 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$27038.26 10-K · filed 2025-03-31 | -$108.15 10-K · filed 2024-04-16 | |||
| 2023-09-30 | -$1950.94 10-Q · filed 2024-11-18 | -$48.77 10-Q · filed 2023-11-14 | -$195.52 derived: net income ÷ weighted average shares · filed 2024-11-18 | -$5477.66 10-Q · filed 2024-11-18 | -$136.94 10-Q · filed 2023-11-14 | -$315.33 derived: net income ÷ weighted average shares · filed 2024-11-18 | ||
| 2023-06-30 | -$36.79 10-Q · filed 2024-08-19 | -$0.92 10-Q · filed 2023-08-14 | -$8682.00 10-Q · filed 2024-08-19 | -$2.17 10-Q · filed 2023-08-14 | -$159.98 derived: net income ÷ weighted average shares · filed 2024-08-19 | -$268.56 derived: net income ÷ weighted average shares · filed 2024-08-19 | ||
| 2023-03-31 | -$52.46 10-Q · filed 2024-05-20 | -$1.31 10-Q · filed 2023-05-15 | -$130.03 derived: net income ÷ weighted average shares · filed 2024-05-20 | -$256.72 derived: net income ÷ weighted average shares · filed 2024-05-20 | -$80.85 derived: net income ÷ weighted average shares · filed 2024-05-20 | |||
| 2022-12-31 | -$78.72 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$225.00 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$50.14 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$597.12 10-K · filed 2024-04-16 | -$14.89 10-K · filed 2023-04-17 | |||
| 2022-09-30 | -$210.93 10-Q · filed 2023-11-14 | -$5.27 10-Q · filed 2022-11-14 | -$19.75 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$720.54 10-Q · filed 2023-11-14 | -$18.01 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | -$6.42 10-Q · filed 2023-08-14 | -$0.13 10-Q · filed 2022-08-15 | -$13.21 10-Q · filed 2023-08-14 | -$0.26 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | -$6.80 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | -$121.18 10-K · filed 2023-04-17 | |||||||
| 2021-09-30 | -$28.08 10-Q · filed 2022-11-14 | -$73.08 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.42 10-Q · filed 2022-08-15 | -$0.88 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |